Skip to main content
OSCOTECInc. logo

OSCOTECInc. — Investor Relations & Filings

Ticker · 039200 ISIN · KR7039200001 KO Manufacturing
Open in API
Filings indexed 271 across all filing types
Latest filing 2025-03-10 Proxy Solicitation & In…
Country KR South Korea
Listing KO 039200

About OSCOTECInc.

https://oscotec.com/

Oscotec Inc. is a clinical-stage drug discovery and development company focused on translating scientific research into innovative medicines for clinically unmet needs. The company's development pipeline targets various diseases, with a primary focus on immunology, oncology, and neurodegenerative disorders. Key therapeutic areas include rheumatoid arthritis, immune thrombocytopenia, non-small cell lung cancer, acute myeloid leukemia, and Alzheimer's disease. Oscotec specializes in developing novel kinase inhibitors, such as Spleen Tyrosine Kinase (SYK) inhibitors, to address these conditions.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) for Oscotec Inc. It contains detailed information regarding the upcoming Annual General Meeting (AGM), including the agenda, voting procedures, electronic voting instructions, and the solicitation of proxies from shareholders. This document is a standard regulatory filing used to solicit votes for a shareholder meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-03-10 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides the date, time, location, and purpose of the meeting, and mentions that materials will be posted on the KRX website on the day of the event. Since this is an announcement of an event rather than the presentation materials themselves, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2025-03-07 Korean
소송등의제기ㆍ신청(경영권분쟁소송) (주주총회결의무효확인소송)
Legal Proceedings Report Classification · 1% confidence The document is a formal regulatory disclosure regarding a lawsuit ('주주총회결의무효확인소송' - Lawsuit for Nullification of General Meeting Resolution) filed against the company. It details the case name, plaintiffs, claims, and the court involved. This falls under the category of legal proceedings or regulatory disclosures regarding litigation.
2025-02-28 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (Oscotec) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) for listed companies to report preliminary financial results before the final audit report is published. It provides key financial highlights (revenue, operating profit, net income) and the reasons for the change. It fits the definition of an Earnings Release (ER) as it is an initial announcement of financial results. FY 2024
2025-02-26 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of an upcoming Annual General Meeting (AGM) for the company 'Oscotec'. It details the date, location, and specific agenda items, including the approval of financial statements, election of directors, and proposed amendments to the articles of incorporation. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and the matters to be voted upon, which aligns with the definition of Proxy Solicitation & Information Statement (PSI).
2025-02-26 Korean
주주총회집중일개최사유신고
AGM Information Classification · 1% confidence The document is a formal regulatory filing titled '주주총회 집중일 개최 사유 신고' (Report on the reason for holding a general meeting on a concentrated date). It explains why the company, Oscotec, scheduled its shareholder meeting on a date that coincides with other companies' meetings, citing accounting and audit schedules. This is a standard regulatory disclosure required by the KOSDAQ exchange for companies holding meetings on 'concentrated' dates. Since it does not fit into specific categories like AGM-R (presentation materials) or PSI (proxy solicitation), it falls under the general regulatory filing category.
2025-02-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.